Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
12.4Enterprise Value over EBITDA
VS
Market
Sector
Industry
History
$ 12.16Close
$ 5.86 - $ 16.56 52-Week Range
Ticker Information
Ticker
CRMDCompany Name
CORMEDIX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCORMEDIX INC - Enterprise Value over EBITDA Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CRMD - EV/EBITDA Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | Enterprise Value | Enterprise Value over EBITDA |
|---|---|---|---|
| 6/30/2025 | $ 52.25M | $ 648.08M | 12.4 |
| 3/31/2025 | $ 17.67M | $ 691.11M | 39.12 |
| 12/31/2024 | $ -18.98M | $ 438.3M | 0 |
| 9/30/2024 | $ -47.32M | $ 575.08M | 0 |
| 6/30/2024 | $ -54.34M | $ 246.88M | 0 |
| 3/31/2024 | $ -51.52M | $ 262.7M | 0 |
| 12/31/2023 | $ -46.23M | $ 144.98M | 0 |
| 9/30/2023 | $ -39.68M | $ 118.87M | 0 |
| 6/30/2023 | $ -36.79M | $ 223.19M | 0 |
| 3/31/2023 | $ -33.71M | $ 209.07M | 0 |
Key Performance Insights, Last 5 Years
- CORMEDIX INC's latest trailing twelve months (TTM) EV/EBITDA stands at 0.
- Over the past 5 years, CORMEDIX INC's average EV/EBITDA has been 25.76.
- The median EV/EBITDA for CORMEDIX INC during this period was 25.76
- CORMEDIX INC reached its highest EV/EBITDA over the past 5 years at 39.12.
- The lowest EV/EBITDA recorded by CORMEDIX INC in the same timeframe 12.4
CORMEDIX INC's EV/EBITDA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/EBITDA Benchmarks
Similar metrics to EV/EBITDA:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) - [Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
Definition of Enterprise Value over EBITDA
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].EV / EBITDA
(=) EV/EBITDA EV/EBITDA for CORMEDIX INC is calculated as follows: EV [ $ 139.38M ] / EBITDA [ $ -26.31M ]
(=) EV/EBITDA [ 0 ] CRMD - Enterprise Value over EBITDA, Last 5 years
12.4
Minimum
Jun 30, 2025
39.12
Maximum
Mar 31, 2025
25.76
Average
25.76
Median
EV/EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.48 with a standard deviation of 7.65.
The following table provides additional summary stats:
EV/EBITDA in the Market:
| filtered constituents | 2.44K |
|---|---|
| min | 0.01 |
| max | 40.82 |
| average | 13.48 |
| median | 11.75 |
| std | 7.65 |